| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.002 |